Yinzhi Yi

发表

Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA

X. Wan, Ye Peng, Jingyan Wang, 2022, Advances in Therapy.

Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA

Chongqing Tan, X. Wan, Xiaohui Zeng, 2022, Advances in Therapy.